References
- Murphy ED RJ. Autoimmunity and lymphoproliferation: Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Rose NR, Bigazzi PE, Werner NL (eds.). Genetic Control of Autoimmune Disease. New York: Elsevier North Holland Inc; 1978, pp. 207–21.
- Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978;148(5):1198–215.
- Ebling F, Hahn BH. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates. Arthritis Rheum. 1980;23(4):392–403.
- Nardella FA, Teller DC, Izui S, Mannik M. Self-associating IgG rheumatoid factors in MRL/l autoimmune mice. Arthritis Rheum. 1984;27(10):1165–73.
- Izui S, McConahey PJ, Theofilopoulos AN, Dixon FJ. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med. 1979;149(5):1099–116.
- Koffler D, Schur PH, Kunkel HG. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967; 126(4):607–24.
- Winfield JB, Faiferman I, Koffler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J Clin Invest. 1977;59(1):90–6.
- Madaio MP, Shlomchik MJ. Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis. B cells have multiple roles; all autoantibodies are not equal. J Am Soc Nephrol. 1996;7(3): 387–96.
- Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol. 1991;147(2):515–9.
- Takahashi S, Itoh J, Nose M, Ono M, Yamamoto T, Kyogoku M. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse. Mol Immunol. 1993;30(2):177–82.
- Itoh J, Nose M, Takahashi S, Ono M, Terasaki S, Kondoh E, Kyogoku M. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse. Am J Pathol. 1993; 143(5):1436–43.
- Churg J, Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Diseases. 2nd edn. Tokyo: Igaku Shoin; 1995.
- Ito MR, Terasaki S, Kondo E, Shiwaku H, Fukuoka Y, Nose M. Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies. Clin Exp Immunol. 2000;119(2):340–5.
- Brady HR. Leukocyte adhesion molecules and kidney diseases. Kidney Int. 1994;45(5):1285–300.
- Wiggins RC, Holzman LB, Legault DJ. Glomerular Inflammation and Crescent Formation. Philadelphia: Lippincott-Raven, Inc; 1997.
- Wilson CB. Immune Models of Glomerlar Injury. Philadelphia: Lippincott-Raven, Inc; 1997.
- Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995;57:827–72.
- Lasky LA. Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem. 1995;64:113–39.
- Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996;88(9):3259–87.
- Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev. 1999;79(1):181–213.
- Nakatani K, Fujii H, Hasegawa H, Terada M, Arita N, Ito MR, et al. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models. Kidney Int. 2004; 65(4):1290–300.
- Nose M, Wigzell H. Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci U S A. 1983;80(21): 6632–6.
- Garvey JS, Cremer NE, Sussdorf DH. Methods in Immunology. 3rd edn. Tokyo: Benjamin Inc.; 1977.
- Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108(2):193–9.
- Azuma A, Takahashi S, Nose M, Araki K, Araki M, Takahashi T, et al. Role of E-selectin in bleomycin induced lung fibrosis in mice. Thorax. 2000;55(2):147–52.
- Mikulowska-Mennis A, Taylor TB, Vishnu P, Michie SA, Raja R, Horner N, et al. High-quality RNA from cells isolated by laser capture microdissection. Biotechniques. 2002;33(1):176–9.
- Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991;67(6):1033–6.
- Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A. 1987;84(24):9238–42.
- Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989;243(4895):1160–5.
- Ley K, Allietta M, Bullard DC, Morgan S. Importance of E-selectin for firm leukocyte adhesion in vivo. Circ Res. 1998;83(3):287–94.
- Milstone DS, Fukumura D, Padgett RC, O’Donnell PE, Davis VM, Benavidez OJ, et al. Mice lacking E-selectin show normal numbers of rolling leukocytes but reduced leukocyte stable arrest on cytokine-activated microvascular endothelium. Microcirculation. 1998; 5(2–3):153–71.
- Nakatani K, Yoshimoto S, Asai O, Sakan H, Terada M, Saito Y, et al. Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice. Immunity Inflamm Dis. 2013;1(1):37–46.
- Perrin LH, Lambert PH, Miescher PA. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest. 1975;56(1):165–76.
- Trinder PK, Maeurer MJ, Schorlermmer HU, Loos M. Autoreactivity to mouse C1q in a murine model of SLE. Rheumatol Int. 1995;15(3): 117–20.
- Williams PG, Peters DK, Fallows J, Petrie A, Kourilsky O, Morel-Maroger L, Cameron JS. Studies of serum complement in the hypocomplementemic nephritides. Clin Exp Immunol. 1974;18(3):391–405.